2 not yet recruiting, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 2, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Adjuvant treatment: new trials by email Literature Review of Adjuvant treatment trials Research Report on Adjuvant treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Pembrolizumab in Patients With High Risk, Stage IIB/IIC Cutaneous Melanoma: a Single Arm Proof of Concept Phase IIA Study. Pembrolizumab neoadjuvant treatment, surgery, Adjuvant treatment - Stage IIB Melanoma, Stage IIC Melanoma | Phase 2 | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 19 | 2026-11-01 | 2026-10-20 |
| Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC Adebrelimab, Adjuvant treatment - Lung Neoplasm Malignant | Phase 2 | Not yet recruiting | Ruijin Hospital | 64 | 2026-10-20 | 2026-10-22 |
| Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. Radiation Therapy, Chemoradiotherapy, Consolidation Chemotherapy - Rectal Cancer, Total Neoadjuvant Treatment | Phase 2 / Phase 3 | Recruiting | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | 400 | 2025-01-06 | 2026-05-11 |
| Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas Neoadjuvant treatment, Adjuvant treatment - Neuroendocrine Carcinoma, Digestive Cancer | Phase 2 | Recruiting | GERCOR - Multidisciplinary Oncology Cooperative Group | 78 | 2021-01-05 | 2025-07-23 |
| Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer Neoadjuvant chemoradiotherapy, Adjuvant chemoradiotherapy - Esophageal Cancer | Phase 2 | Unknown | Zhejiang Cancer Hospital | 60 | 2011-10-01 | 2013-05-14 |
| Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) Sunitinib, Placebo - Renal Cell Carcinoma, Pulmonary Metastases | Phase 2 | Terminated | Association of Urologic Oncology (AUO) | 60 | 2010-10-01 | 2026-08-25 |
Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Esophageal Neoplasms (1) · Fatigue (1) · Gastrointestinal Neoplasms (1) · Low Anterior Resection Syndrome (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Postoperative Complications (1) · Radiation Injuries (1) · Rectal Neoplasms (1)
Association of Urologic Oncology (AUO) (1) · Centre Hospitalier Universitaire de Besancon (1) · GERCOR - Multidisciplinary Oncology Cooperative Group (1) · National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos (1) · Ruijin Hospital (1) · Zhejiang Cancer Hospital (1)
China (2) · France (2) · Germany (1) · Lithuania (1)
Audrius Dulskas, PhD (1) · Hecheng Li, MD, PhD (1) · Jingyuan Fan, MD, PhD (1) · Runsen Jin, MD, PhD (1) · Susanne Krege, Priv. Doz. Dr. med. (1) · Weimin Mao, MD (1) · Yichao Han, MD, PhD (1)
2008 (1)